LIF Mouse

Leukemia Inhibitory Factor Mouse Recombinant
Cat. No.
BT19449
Source
Escherichia Coli.
Synonyms
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia inhibitory factor, LIF, DIA.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Leukemia Inhibitory Factor (LIF) Murine Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 181 amino acids and having a molecular mass of 20 kDa.
The Leukemia Inhibitory Factor (LIF) is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Leukemia Inhibitory Factor (LIF) is a protein that plays a crucial role in maintaining embryonic stem cells. It prevents these cells from spontaneously changing into other cell types. LIF also has other functions, including aiding in the development of nerve cells that use acetylcholine, regulating stem cell versatility, influencing bone and fat metabolism, stimulating the growth of certain cell lines, and boosting the production of megakaryocytes (cells that produce platelets). The LIF proteins in humans and mice share a 78% similarity in their amino acid sequence.
Description
Recombinant Murine Leukemia Inhibitory Factor (LIF) is a single-chain protein produced in E. coli bacteria. It is not glycosylated, meaning it lacks attached sugar molecules. It comprises 181 amino acids and has a molecular weight of 20 kDa. The purification process utilizes specialized chromatographic methods to ensure its purity.
Physical Appearance
Sterile white powder obtained by freeze-drying.
Formulation
The Leukemia Inhibitory Factor (LIF) was freeze-dried from a sterile solution with a concentration of 1mg/ml. The solution contained 20mM Phosphate buffer with a pH of 7.4 and 0.02% Tween-20.
Solubility
To reconstitute the freeze-dried Leukemia Inhibitory Factor (LIF), it is advised to dissolve it in sterile water to a minimum concentration of 100µg/ml. This solution can be further diluted using other aqueous solutions.
Stability
While the lyophilized (freeze-dried) Leukemia Inhibitory Factor (LIF) remains stable at room temperature for up to 3 weeks, it is best stored in a dry environment below -18°C. Once reconstituted, store Leukemia Inhibitory Factor (LIF) at 4°C for a maximum of 7 days. For extended storage, freeze at -18°C. The addition of a carrier protein such as HSA or BSA (0.1%) is recommended for long-term storage. Avoid repeated freezing and thawing cycles.
Purity
The purity is confirmed to be higher than 95.0% through the following analyses: (a) RP-HPLC (Reverse Phase High-Performance Liquid Chromatography), and (b) SDS-PAGE (Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis).
Biological Activity
The biological activity of murine LIF is evaluated using the M1 cell differentiation assay. The activity is determined to be less than 0.01 ng/ml, which translates to a specific activity of 100,000,000 IU/mg. The definition of a standard of 50 units is the LIF concentration in 1.0 mL of cell culture medium that triggers the differentiation of 50% of M1 colonies.
Synonyms
CDF, HILDA, D-FACTOR, Differentiation- stimulating factor, Melanoma-derived LPL inhibitor, MLPLI, Emfilermin, Leukemia inhibitory factor, LIF, DIA.
Source
Escherichia Coli.
Amino Acid Sequence
MSPLPITPVNATCAIRHPCHGNLMNQIKNQLAQLNGSANALFISYYTAQGEPFP NNVEKLCAPNMTDFPSFHGNGTEKTKLVELYRMVAYLSASLTNITRDQKVLNP TAVSLQVKLNATIDVMRGLLSNVLCRLCNKYRVGHVDVPPVPDHSDKEAFQR KKLGCQLLGTYKQVISVVVQAF.

Product Science Overview

Discovery and Nomenclature

LIF was first identified in the late 1960s when researchers observed that conditioned medium could induce differentiation in murine myeloid leukemia cells . Over the years, LIF has been rediscovered multiple times in different contexts, leading to various names such as Differentiation-Inducing Factor (D-Factor), Differentiation-Stimulating Factor (DSF), and Human Interleukin for DA cells (HILDA) .

Structure and Function

LIF is a glycoprotein that functions by binding to its specific receptor, LIF receptor (LIFR), which forms a heterodimer with the gp130 signal transducing subunit . This interaction activates several intracellular signaling pathways, including the JAK/STAT, PI3K, and MAPK pathways . These pathways are essential for the cytokine’s diverse biological effects.

Role in Embryonic Stem Cells

In mice, LIF is a key factor that prevents embryonic stem cells (ESCs) from differentiating . It is often added to stem cell culture media to maintain the pluripotency of ESCs, allowing them to self-renew and proliferate without differentiating . This property makes LIF invaluable in stem cell research and regenerative medicine.

Recombinant Production

Recombinant mouse LIF is produced using various expression systems, including bacterial, yeast, and mammalian cells . The recombinant form retains the biological activity of the native protein and is widely used in research and therapeutic applications.

Clinical Implications

LIF has shown promise in various clinical applications, including the treatment of myeloid leukemia and thrombocytopenia . Its ability to influence a wide range of cell types, including neurons, adipocytes, osteoblasts, and gonadal cells, makes it a versatile therapeutic agent .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.